VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

Mimoun Azzouz; G. Ralph; Erik Storkebaum; Lucy E. Walmsley; Kyriacos Mitrophanous; Susan M. Kingsman; Peter Carmeliet; Nicholas D. Mazarakis

doi:10.1038/nature02544

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2004

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS

Erik Storkebaum, Diether Lambrechts, Mieke Dewerchin, Paz Moreno-Murciano, Saskia Appelmans, Hideyasu Oh, Philip Van Damme, Bart P. F. Rutten, W.Y. Man, Maria De Mol, Sabine Wyns, David Manka, Kristel Vermeulen, Ludo Van Den Bosch, Nico Mertens, Christoph Schmitz, Wim Robberecht, Edward M. Conway, D Collen, Lieve Moons, Peter Carmeliet

Article2005

A novel role for VEGF-B in motorneuron degeneration in ALS

Diether Lambrechts, Peggy Lafuste, Désiré Collen, Mieke Dewerchin, Lieve Moons, Peter Carmeliet

Article2020

Transdermal delivery of topical lidocaine in a mouse model is enhanced by treatment with cold atmospheric plasma

Yue Xin, Xiang Wen, Michael R Hamblin, Xian Jiang

Chapter in a book2006

VEGF, an Angiogenic Factor with Neurotrophic Activity, Useful for Treatment of ALS?

Diether Lambrechts, Peter Carmeliet

Article2000

CTLA4Ig Gene Transfer Prolongs Survival and Induces Donor-Specific Tolerance in a Rat Renal Allograft

Susanna Tomasoni, Nadia Azzollini, Federica Casiraghi, Maurizio C. Capogrossi, Giuseppe Remuzzi, Ariela Benigni